tldrdaily.news logo
Tag

Takeover Interest

All articles tagged with #takeover interest

business2 years ago

Paramount's Stock Soars Amidst Takeover Speculation

Shares of Paramount Global surged over 14% after reports emerged that Skydance and Redbird Capital are exploring the possibility of taking over the media giant. Paramount, which has a market cap of $10.5 billion, has been facing declining revenue and streaming losses. The company's controlling shareholder, Shari Redstone, has shown interest in making significant deals. Redbird Capital, known for its investments in media and sports assets, including Skydance, is reportedly involved in the potential takeover. Paramount is also considering bundling its streaming service, Paramount+, with Apple TV+.

via CNBC|
#business#paramount#redbird-capital
business2 years ago

Hostess Brands Considers Sale Amid Takeover Interest

Hostess Brands, the maker of Twinkies and other snack cakes, is considering a sale after receiving interest from major snack food companies. The company's decision to raise prices on some products to boost revenue has sparked concerns among investors. General Mills, Mondelez International, PepsiCo, and Hershey are among the potential buyers. Hostess has hired Morgan Stanley to advise on the negotiations, but no agreement is guaranteed. Hostess shares rose 26% on the news, giving the company a market value of nearly $4 billion.

via CNBC|
#acquisition#business#hostess-brands
manda2 years ago

Sale interest in Buy Buy Baby during Bed Bath & Beyond bankruptcy.

Buy Buy Baby is attracting takeover interest from at least two bidders as Bed Bath & Beyond seeks to sell off assets in its bankruptcy process. One bidder is Babylist, a direct-to-consumer baby registry website, while the other is unknown but plans to keep 75% of the stores open. Some bidders are also interested in buying Bed Bath & Beyond's digital assets.

via Seeking Alpha|
#bankruptcy#bed-bath-and-beyond#bidders
business2 years ago

Apellis Biotech Attracts Takeover Interest in US

Apellis Pharmaceuticals, a biotech firm focused on rare diseases and ophthalmology, is reportedly attracting takeover interest from larger drugmakers. The company is considering its options amid the interest and may also seek partnerships or licensing agreements for some of its ophthalmology products. Apellis recently received FDA approval for its treatment for an advanced eye disorder that's a leading cause of blindness, and a deal would continue a trend in health-care dealmaking that's seen large pharmaceutical companies buy safer, later-stage biotechs with approved products that can help replace revenue from blockbuster drugs going off patent.

via Yahoo Finance|
#apellis-pharmaceuticals#biotech#business